RUMORED BUZZ ON CONOLIDINE PROLEVIATE FOR JOINT PAIN TREATMENT

Conolidine’s analgesic consequences stem from its interaction with non-opioid pain pathways. As opposed to opioids, which bind to µ-opioid receptors in the central nervous technique, conolidine modulates alternate molecular targets. A Science Innovations review identified that conolidine interacts Along with the atypical chemokine receptor ACKR3